Beyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma
International Ophthalmology · 22.07.2026 · 46 (1)
DOI: 10.1007/s10792-026-04189-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Ophthalmology, online erschienen am 22.07.2026. Verfasst von Balaji Lakavath und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Central Research Laboratory for Biomedical Research, Vinayaka Mission's Kirupananda Variyar Medical College & Hospitals,…. Hauptthemen laut MEDLINE: Intraocular Pressure, Glaucoma, Blood Pressure, Optic Nerve. Die Arbeit nennt 72 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To critically integrate epidemiological, mechanistic, and clinical evidence linking systemic blood pressure dysregulation and diabetes mellitus with glaucomatous optic nerve injury, while distinguishing biological plausibility and association from demonstrated causality. METHODS: PubMed/MEDLINE was searched from database inception through 30 June 2026 using three prespecified blocks covering blood pressure exposures, diabetes and candidate antidiabetic therapies, and glaucoma subtypes. Backward citation tracking and targeted journal and publisher searches identified additional and recently published studies. Owing to clinical and methodological heterogeneity, evidence was synthesised as a structured narrative review. RESULTS: Chronic hypertension may be associated with higher intraocular pressure, vascular remodelling, and impaired autoregulation, whereas systemic hypotension, nocturnal over-dipping, and blood pressure variability may reduce or destabilize ocular perfusion. Diabetes has plausible microvascular, metabolic, and neurodegenerative effects, but epidemiological findings are inconsistent and glycated haemoglobin does not consistently predict glaucoma progression. Evidence is strongest for primary open-angle and normal-tension glaucoma. Findings concerning metformin, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter-2 inhibitors remain predominantly observational, genetic, translational, or preclinical. CONCLUSION: Systemic vascular and metabolic factors may modify optic nerve susceptibility but are not established independent causes or treatment targets. Intraocular pressure lowering remains the therapeutic cornerstone, and prospective glaucoma-specific intervention studies are needed before systemic treatment recommendations can be made.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Central Research Laboratory for Biomedical Research, Vinayaka Mission's Kirupananda Variyar Medical College & Hospitals, Vinayaka Mission's Research Foundation (Deemed to be University), Sal…
Zitieren
APA
Lakavath, B., Kumar, B. S., & Nelaturi, P. (2026). Beyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04189-2
Vancouver
Lakavath B, Kumar BS, Nelaturi P. Beyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04189-2
BibTeX
@article{Lakavath2026,
author = {Lakavath, Balaji and Kumar, B Senthil and Nelaturi, Prabhudas},
title = {Beyond intraocular pressure: vascular and metabolic modifiers of optic nerve vulnerability in glaucoma},
journal = {International Ophthalmology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10792-026-04189-2}
}
EUVIMED